Yanling Wang1, Shijie Yin1,2, Shixiong Wang1,2

  • 1Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Healthcare Affiliated to Hunan Normal University, Changsha, China.

PubMed
概括

这项研究确定了对耐利芬素脊柱结核病 (DSTB) 的关键蛋白标,为新药开发铺平了道路. 蛋白质组分析显示了显著的蛋白质变化,为改善DSTB治疗策略提供了希望.